Delivery Order SPE2DB24D3014-SPE2DB24FKSFJ
Award Date
9/13/24
Potential Completion Date
9/16/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,479.00 firm fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of June 18, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,930.30 firm-fixed-price contract is for the supply of RABAVERT rabies vaccine with diluent. The order has a completion date of July 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to federal agencies, including the military. The company holds several Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,239.50, is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The $2,316.36 firm fixed-price contract has a completion date of July 23, 2024 and is not set aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for a comprehensive range of medical...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA). The contract, valued at $13,515.30, is for the supply of RABAVERT rabies vaccine with diluents. It is a firm fixed-price contract with a completion date of June 10, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds two Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,493.00 firm-fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. The delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,095.80, is for the supply of RABAVERT rabies vaccine with diluents. It is a firm fixed-price contract with a completion date of March 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,437.00, is for the delivery of RABAVERT rabies vaccine with diluents. It is a firm fixed-price delivery order contract with a period of performance through March 2025. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen also...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $57,909.00, is for the supply of RABAVERT rabies vaccines with diluents. The contract has a completion date of July 31, 2024 and is a firm fixed price, delivery order type contract. There is no set-aside designation. AmerisourceBergen, through its extensive supply chain network, will provide these critical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $84,612.28 firm fixed price contract is for the supply of RABAVERT rabies vaccine with diluents. There is no set-aside designation for this contract. The ultimate completion date is August 2, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for providing a wide range of pharmaceutical and...